True or False? Normal Fasting Blood Sugar Reading Should Range Between 80-120 Mg/dl.

Definition

Glucose is the nigh important carbohydrate fuel in the body. In the fed land, the bulk of circulating glucose comes from the diet; in the fasting state, gluconeogenesis and glycogenolysis maintain glucose concentrations. Very piffling glucose is found in the nutrition as glucose; almost is establish in more complex carbohydrates that are cleaved downwardly to monosaccharides though the digestive process. About half of the full carbohydrates in the diet are in the grade of polysaccharides and the remainder as simpler sugars. About two-thirds of the carbohydrate in the diet is sucrose, which is a disaccharide of glucose and fructose. Glucose is classified equally a monosaccharide because it cannot be broken downwardly further by hydrolysis. Information technology is further classified equally a hexose considering of its six-carbon skeleton and as an aldose, considering of the presence of an aldehyde group on carbon 1. The aldehyde group condenses with a hydroxyl group so that glucose exists equally a hemiacetal ring construction. This ring construction explains many of the reactions of glucose.

Ordinarily the concentration of glucose in the blood is maintained at a relatively stable concentration from 80 to 120 mg/dl. The potent reducing properties of glucose made it relatively easy to measure and thus the clinical interpretation of circulating glucose was i of the earliest tests available to the clinician. The recent introduction of microglucose oxidase applied science has now made it possible for the patient to measure out his or her own blood glucose concentration and undoubtedly makes the estimation of blood glucose the almost widely used exam of claret chemistry. An understanding of the methods of blood glucose measurement will help the clinician to interpret values and avoid the pitfalls of inaccurate testing.

Technique

The concentration of glucose is highest in the arterial circulation. Laboratory determinations are usually washed on venous samples. If the venous circulation is delayed, such as past leaving a tourniquet on for a prolonged period of fourth dimension, the concentration falls even further. Thus, samples should be obtained after releasing the tourniquet. Studies have shown that blood glucose concentration may fall every bit much as 25 mg/dl when a tourniquet has been left in place for 6 minutes. The concentration of glucose in capillary samples is intermediate betwixt venous and arterial. Warming the extremity increases the capillary period and "arterializes" the sample, while cooling or a tourniquet decreases the flow and lowers the concentration of glucose.

Both scarlet cells and leukocytes comprise glycolytic enzymes. Therefore glucose will be consumed and the concentration of glucose in a sample of whole blood will turn down with time. The rate of loss is mostly said to be approximately 5% per hour, only may be equally rapid as 40% in 3 hours. Consumption of glucose in whole blood samples can exist prevented past adding sodium fluoride to the specimen to inhibit the glycolytic enzymes. This approach is the generally practical method in the clinical laboratory. It is effective except in situations where the arrangement is overwhelmed, such as in specimens from patients with leukemia, which contain large numbers of leukocytes. Sodium fluoride has a major disadvantage in that its use makes the sample unacceptable for other determinations such every bit sodium and uric acid.

Rapid separation of the sample or cooling will also forbid glycolysis and will allow the sample to be used for other determinations. Unhemolyzed samples that have been separated inside 30 minutes of drawing are generally considered adequate. Rapid cooling of the sample followed by centrifugation is even more effective in preventing glycolysis. These methods require more attending to particular and are therefore not suitable for routine laboratory utilize. On occasion, circumstances will require that the glucose concentration exist determined on an ordinary serum sample. If the specimen has been promptly centrifuged, it is reasonable to enquire the laboratory to mensurate the glucose concentration even though a sodium fluoride (green top) tube was not used.

Glucose concentration may exist determined in whole claret, plasma, or serum samples. If whole blood is used, the concentration will be lower than if plasma or serum is used. This is due to the greater water content of the cellular fraction. Under usual circumstances, the concentration of glucose in whole blood is about 15% lower than in plasma or serum, but the difference will be less in patients with low hematocrits.

Claret glucose cannot be adamant accurately on postmortem specimens considering both glycogenolysis and glycolysis continue afterward expiry. A reasonable estimate of the antemortem blood glucose concentration can exist obtained by measuring the glucose concentration of the vitreous of the eye, which does not contain glycolytic enzymes.

Home Glucose Monitoring

Glucose oxidase and reagents to measure the generation of hydrogen peroxide can exist bonded to filter paper and the system used to measure glucose concentrations in a drop of capillary blood. This has resulted in the near important change in diabetes management since the introduction of insulin.

Patients are instructed to obtain a blood sample by pricking their fingertip with a lancet. Spring-loaded lancets are available. They are easy to use and cause minimal discomfort. Surprisingly, many patients consider the discomfort of the finger stick preferable to the inconvenience and aesthetic unpleasantness of obtaining a urine sample for testing. A drop of whole capillary blood is then placed on the reagent bonded to the paper strip. Instead of using a known volume of blood, an excess of blood is exposed to a fixed quantity of glucose oxidase for a finite period of fourth dimension to estimate concentration. After the specified time, usually 1 minute, the excess blood is removed by washing or wiping and the colour is allowed to develop. The concentration is and then estimated by comparison to a color chart, or past using a portable reflectance meter specific to the reagent strip, to measure the adult color. Reflectance meters for measuring claret glucose are becoming increasingly sophisticated, compact, and reliable. Shirt-pocket-sized models are now bachelor, and image models that shop the time, engagement, result, and insulin doses for later graphic printing at the patient's dwelling or physician's office have been developed. Undoubtedly, reflectance meters that have admission to complex algorithms for recommending changes in insulin dose individualized to a specific patient will exist possible in the near futurity.

Glycosylated Hemoglobin

A test that reflects long-term blood glucose control in diabetics is the concentration of hemoglobin A1c. When hemolysates of carmine cells are chromatographed, three or more small peaks named hemoglobin A1a, A1b, and A1c are eluted before the main hemoglobin A peak. These "fast" hemoglobins are formed by the irreversible attachment of glucose to the hemoglobin in a two-step reaction. The pct of hemoglobin glycosylated depends on the average glucose concentration the red cell is exposed to over time. Since the average life of the cherry-red prison cell is 120 days, the per centum of glycosylated hemoglobin gives a good indication of the degree of claret sugar control over the preceding weeks. Hemoglobin A1c is quantifiably the largest elevation so that most laboratories measure it selectively, although some laboratories measure all the "fast" hemoglobins. Numerous biochemical methods are used including electrophoresis, mini columns, radioimmunoassay, and loftier-force per unit area liquid chromatography. Unfortunately, there are no standards or reference methods for this examination. Some methods include a labile hemoglobin Ale in their measurement. This is reversibly glycosylated hemoglobin A that is dependent on the current blood glucose concentration and can falsely elevate results. Therefore it is important to know the local hospital norms and variations.

Glucose Tolerance Testing

In 1979, an international work group sponsored by the National Diabetes Data Grouping of the National Institutes of Health developed a nomenclature framework and criteria for the diagnosis of diabetes mellitus. The recommendations are endorsed by the American Diabetes Association and other groups. The classification and criteria are summarized in Table 141.1. Frequently, the diagnosis of diabetes mellitus can exist made based on elevated random or fasting blood sugars. In special circumstances, a glucose tolerance test is needed to establish the diagnosis.

The test should be done in the morning, after a 10- to fourteen-hour fast in which the patient is permitted only water. Patients are not immune to smoke during the test. A fasting claret sugar is obtained. Adults are and then given a potable containing 75 1000 of glucose (the 75 1000 dose is actually a compromise between the European custom of giving 50 grand and the Us custom of giving 100 thousand). Children are given 1.75 k/kg platonic body weight up to 75 g, and significant patients are given 100 thousand of glucose (the older 100 g dose is retained for significant patients because all information on pregnancy result is based on tests using the 100 one thousand load). Timing is begun when the patient begins to potable the glucose solution. Blood samples are obtained every 30 minutes for two hours in adults and children. For significant patients, claret samples are obtained every hour for 3 hours. Criteria for interpretation are given in Table 141.ane.

Basic Science

At that place are iii basic approaches to the laboratory measurement of claret glucose concentration: reducing methods, condensation methods, and enzymatic methods. Reducing methods are the oldest and take advantage of the reducing properties of glucose to change the state of a metal ion while glucose is being oxidized. Reducing methods are nonspecific, and whatsoever strong reducing agent can cross react to yield spuriously elevated values. While steps can exist added to remove about cantankerous-reacting reducing agents, this approach has largely been abandoned in the clinical laboratory.

The aldehyde grouping of glucose tin undergo condensation with aromatic compounds to yield a colored product. In the most commonly used condensation reaction, o-toluidine reacts with glucose to form a glucosamine that has an intense green colour. The color is then measured spectrophotometrically to estimate the glucose concentration. The reaction is rapid, and the intense colour allows a high degree of sensitivity. Other aldoses can cantankerous react, merely only mannose and galactose requite a highly colored production. These sugars are not constitute in great concentrations in the blood and their cross reactivity is ordinarily non pregnant. o-Toluidirie has the drawback of being highly corrosive and toxic. For this reason, this method is rapidly being phased out of the clinical laboratory.

The enzyme glucose oxidase reacts with glucose, h2o, and oxygen to form gluconic acid and hydrogen peroxide. The hydrogen peroxide tin can then exist used to oxidize a chromogen or the consumption of oxygen measured to judge the amount of glucose present. Glucose oxidase is specific for β-d-glucose, then cross reaction with other sugars is non a problem. In aqueous solution, approximately 66% of d-glucose is in the β country and 34% exists as α- d-glucose. The rate of interconversion is pH and temperature dependent. Some methods add a glucomutarostase to the reagents to speed up the conversion to the beta anomere, but this does not seem to alter the clinical results. The measurement of generated hydrogen peroxide is not as specific as the first glucose oxidase reaction. Numerous reducing substances can potentially inhibit the oxidation of the chromogen. Although uric acrid and creatinine, fifty-fifty in uremic patients, seem to take little issue on the results, ascorbic acid will yield spuriously low blood glucose measurements. The high concentration of uric acid institute in urine will affect the consequence and and so glucose oxidase methods are non directly applicable to urine samples. The measurement of oxygen consumption using an oxygen-specific electrode avoids the problem of interfering reducing agents. In general, the glucose oxidase method is relatively cheap and specific.

Clinical Significance

Home Glucose Monitoring

In near hands, the glucose oxidase strip method is accurate and reliable. Since whole blood is used, the results tend to be slightly lower than simultaneous venous samples, but this is balanced past the fact that capillary blood has a higher glucose concentration than venous blood. Near patients can visually estimate the correct value, but a few patients consistently misread the visual charts and must utilize a reflectance meter. This may be due to an unexpectedly high prevalence of disturbances of color perception in diabetics. Nigh patients experience more comfy with the digital readout of the reflectance meter, although it is not necessarily more than accurate. The major sources of error are in failing to put a large enough drop of blood on the strip and inaccurate timing. For patients who employ reflectance meters, another source of error is failure to go on the machine clean and calibrated. Once the colour is developed, it is relatively stable, so patients tin be instructed to bring developed strips to the doctor's office and so that the accuracy can be checked.

Glucose oxidase strips cost about l cents each and reflectance meters average $150. It has been estimated that if xx% of the Type I diabetics in the country were to be involved in a four-fourth dimension-a-day home glucose measurement plan, the approximate annual cost would exist $225 to $645 1000000. On the other hand, the estimated expenditure for the intendance of Type I diabetics in 1982 was in excess of $six billion. The cost of reagents is decreasing. In fact, patients who visually read the reagent strips tin realize a 50% reduction in cost by cutting the strips in half lengthwise. A patient who has a laboratory determination of blood sugar on a weekly or biweekly ground may save money past learning home glucose measurement. This author believes that all Type I (IDDM) diabetics should exist on a frequent home blood glucose monitoring plan. Patients with Type II diabetes mellitus should likewise be taught home glucose monitoring, although the measurements demand not be as frequent.

With third-party hospital payments at present tied to the diagnosis rather than to services rendered (DRGs), hospitals are looking for ways to reduce the cost of laboratory tests. Increasing numbers of hospitals are training ward staff to use glucose oxidase strips to monitor blood sugars, in the aforementioned fashion every bit urine sugars have traditionally been monitored in the infirmary. Before such a plan is instituted, an effective educational program for the staff must be in place also as an effective ways of quality control.

Glycosylated Hemoglobin

Sure conditions, such as uremia, aspirin ingestion, and alcoholism, can cause spurious elevations of glycosylated hemoglobin. Falsely low percentages of glycosylate hemoglobins can be caused by uremia, anemia, variant hemoglobins such as hemoglobin South, and pregnancy. The sensitivity of the measurement of hemoglobin A1c is such that the test cannot exist used to diagnose diabetes, merely it is a useful means of following the blood glucose control of the diabetic patient. The measurement of other glycosylated proteins are being studied and may eventually supercede glycosylated hemoglobin measurements.

Glucose Tolerance Testing

The oral glucose tolerance test is fraught with potential problems, and strict adherence to protocol must exist followed to accomplish a valid determination. Patients must not be experiencing acute medical or surgical stress. They should exist tested several months after recovery. Patients who are chronically malnourished or who have been carbohydrate restricted will have exaggerated blood sugar responses. In general, the patient should have at to the lowest degree a 150 g saccharide intake and normal physical activity for 3 days preceding the test. Patients who have been confined to bed for three or more days should also have the test delayed until after recovery. If possible, patients should discontinue all medications for iii days prior to testing. Patients who have undergone a recent gastrectomy should exist watched carefully for alimentary hypoglycemia.

An abbreviated screening glucose tolerance examination is recommended for all women between their 24th and 28th week of pregnancy. The test consists of 50 grand of oral glucose and the measurement of venous plasma glucose ane hour later. The examination may be administered at whatever fourth dimension of twenty-four hours and not-fasting. A 1 hour plasma glucose of 140 mg/dl or greater indicates the demand for a full-calibration glucose tolerance examination equally described in a higher place.

References

1. Aziz South, Hsiang YH. Comparative study of home blood glucose monitoring devices: Visidex, Chemstrip bH, Glucometer, and Accu-Chek bG. Diabetes Care. 1983;6:529–32. [PubMed: 6653308]

2. Bergman Grand, Felig P. Cocky-monitoring of blood glucose levels in diabetes. Principals and do. Arch Intern Med. 1984;144:2029–34. [PubMed: 6385899]

3. Blaedel WJ, Uhl JM. Nature of materials in serum that interfere in the glucose-oxidase–peroxidase-0-dianisidine method for glucose, and their mode of action. Clin Chim. 1975;21:119–24. [PubMed: 1116263]

4. Coe JI. Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu, 1976. Wecht CH, ed. New York: Appleton-Century-Crofts, 1977;55–92.

5. Dietzler DN, Smith CH. Carbohydrates. In: Sonnenwirth Air conditioning,Jarett L, ed. Gradwohl's clinical laboratory methods and diagnosis. St. Louis: CV Mosby, 1980;210–49.

6. Drucker RF, Williams DR, Price CP. Quality assessment of blood glucose monitors in use exterior the hospital laboratory. J Clin Pathol. 1984;36:948–53. [PMC costless article: PMC498428] [PubMed: 6875021]

7. Goldstein DE, Parker KM, England JD. et al. Clinical awarding of glycosylated hemoglobin measurements. Diabetes. 1982;31(suppl3):seventy–78.

8. Hanrahan JB, Sax SM, Cillo A. Factitious hypoglycemia in patients with leukemia. Am J Clin Pathol. 1963;twoscore:43–45. [PubMed: 13952575]

9. Hotkamp HC, Verhoef NJ, Leijnse B. The difference between the glucose concentration in plasma and whole claret. Clin Chim Acta. 1975;59:41–49. [PubMed: 1122647]

10. Howanitz PJ, Howanitz JH. Carbohydrates. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. Philadelphia: W.B. Saunders, 1984; 168–69.

11. Lombrail P, Cathelineau G, Gervais P. et al. Aberrant color vision and reliable cocky-monitoring of blood glucose. Diabetes Care. 1984;7:318–21. [PubMed: 6331996]

12. Loughlin WC, Mosenthal HO, Halpern R. Result of tourniquets on venous blood sugar values. J Lab Clin Med. 1943;28:1165–seventy.

13. National Diabetes Information Group. Nomenclature and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57. [PubMed: 510803]

14. Overfield CV, Savory J, Heintges MG. Glycolysis: a re-evaluation of the consequence on blood glucose. Clin Chim Acta. 1972;39:35–40. [PubMed: 5038762]

15. Yatscoff RD. et al. Interference of fetal hemoglobin and labile glycosylated hemoglobin with measurements of glycosylated hemoglobin. Clin Chim. 1983;29:543–49. [PubMed: 6186416]

algerthisheatch.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/books/NBK248/

Share this post